Synnovis, a major medical testing and diagnostics provider with partnerships including the NHS, has been hit by a ransomware attack that disrupted its IT systems. The attack, confirmed by CEO Mark Dollar, forced cancellations and redirection of patient activities, significantly impacting delivery of services at Guy’s and St Thomas’, King’s College Hospital and southeast London Primary care services. An IT task force is assessing the damage, with initial reports suggesting only 10% of services are running as normal.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
